ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
239.01
買値
234.00
売値
241.00
出来高
2,125
237.82 日の範囲 239.48
0.00 52 週間の範囲 0.00
前日終値
238.90
始値
239.17
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ANX 最新ニュース

ADVENTRX Announces Management Promotions

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that, effective immediately, Brian M. Culley, previously the Company's Chief Business...

ADVENTRX Appoints Icahn Representative to Board of Directors

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will...

ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Closing of Financing

SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E...

ADVENTRX Pharmaceuticals to Present at the OneMedForum Finance Conference on January 13

SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...

ADVENTRX Pharmaceuticals Announces Financing

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has signed agreements to purchase shares of its Series E convertible preferred...

ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug...

ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference

SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to...

ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514

South Korean Partner Demonstrates Bioequivalence and Similar Toxicity Profile to Taxotere SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today...

ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and nine months ended September 30, 2009. "Our third...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.2B
NUKKNukkleus Inc
US$ 50.68
(326.60%)
54.52M
PLRZPolyrizon Ltd
US$ 3.256
(210.10%)
137.32M
QMCOQuantum Corporation
US$ 60.085
(153.31%)
22.66M
VRARGlimpse Group Inc
US$ 3.1885
(100.53%)
55.04M
XCHXCHG Ltd
US$ 2.16
(-90.74%)
11.17M
FTELFitell Corporation
US$ 5.50
(-85.67%)
1.68M
XHGXChange TED Inc
US$ 0.754
(-52.28%)
549.34k
MHUAMeihua International Medical Technologies Company Ltd
US$ 0.2755
(-43.82%)
8.86M
RNAZTransCode Therapeutics Inc
US$ 3.915
(-38.00%)
854.5k
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.19B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3671
(9.94%)
312.75M
CGTXCognition Therapeutics Inc
US$ 0.58295
(28.15%)
284.82M
RGTIRigetti Computing Inc
US$ 10.684
(-4.01%)
276.65M
NVDANVIDIA Corporation
US$ 128.91
(-1.14%)
273.75M

最近閲覧した銘柄

Delayed Upgrade Clock